ConductScience.org, home

Paper41004466

Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study.

Wang YJ and 6 others. PLoS One, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study. Papers, record 41004466. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41004466

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Paxlovid plus glucocorticoids treatment in severe Omicron infected patients with hypoxaemia: A prospective multiple-center cohort study.
PubMed
Journal
PLoS One
PubMed
Year
2025
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-10-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YJYu-Ji
2Su NNan
3Jiang JHJun-Hong
4Xu GPGuo-Peng
5Wang RRan
6Zeng DXDa-Xionghttps://orcid.org/0000-0002-6476-2974
7Zhu JJiao

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucocorticoidsMajor topic
COVID-19 Drug TreatmentMajor topic
HypoxiaMajor topic
Antiviral AgentsMajor topic
Humans
Male
Female
Middle Aged
Prospective Studies
COVID-19
Aged
SARS-CoV-2
Adult
Drug Therapy, Combination
Treatment Outcome
Hospitalization

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
232958060Glucocorticoid therapy does not delay viral clearance in COVID-19 patients.Crit Care2020https://conductscience.org/library/papers/32958060PubMed
336767517Outcomes of Elderly Patients Hospitalized with the SARS-CoV-2 Omicron B.1.1.529 Variant: A Systematic Review.Int J Environ Res Public Health2023https://conductscience.org/library/papers/36767517PubMed
433486496Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial.Respiration2021https://conductscience.org/library/papers/33486496PubMed
534966985Early corticosteroid initiation delays viral RNA clearance in respiratory secretions of COVID-19 patients.Adv Respir Med2021https://conductscience.org/library/papers/34966985PubMed
633632000A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19.J Intensive Care Med2021https://conductscience.org/library/papers/33632000PubMed
732876695Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.JAMA2020https://conductscience.org/library/papers/32876695PubMed
837757919Effect of dexamethasone dose on outcomes in acute COVID-19 disease: A systematic review and meta-analysis.J Infect2023https://conductscience.org/library/papers/37757919PubMed
936001529Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.N Engl J Med2022https://conductscience.org/library/papers/36001529PubMed
1036777445Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study.Lancet Reg Health West Pac2023https://conductscience.org/library/papers/36777445PubMed
1135653428Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.Clin Infect Dis2023https://conductscience.org/library/papers/35653428PubMed
1234649502Association between glucocorticoids treatment and viral clearance delay in patients with COVID-19: a systematic review and meta-analysis.BMC Infect Dis2021https://conductscience.org/library/papers/34649502PubMed
1332499448Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.Aging (Albany NY)2020https://conductscience.org/library/papers/32499448PubMed
1435172054Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.N Engl J Med2022https://conductscience.org/library/papers/35172054PubMed
1533317589Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.Crit Care2020https://conductscience.org/library/papers/33317589PubMed
1636905638Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone.Infect Dis (Lond)2023https://conductscience.org/library/papers/36905638PubMed
1737515802Dexamethasone, dexamethasone + remdesivir in treating moderate to severe COVID-19: retrospective observational cohort study.J Infect Dev Ctries2023https://conductscience.org/library/papers/37515802PubMed
1833032534Clinical characteristics and manifestations in older patients with COVID-19.BMC Geriatr2020https://conductscience.org/library/papers/33032534PubMed
1933631065Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/33631065PubMed
2035084022
Remdesivir Plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Coronavirus Disease 2019 (COVID-19) Patients Requiring Supplemental O2 Therapy: A Prospective Controlled Nonrandomized Study.
Clin Infect Dis2022https://conductscience.org/library/papers/35084022PubMed

See all 35 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42282861Corticosteroids with or without antiviral therapy in elderly patients hospitalized with COVID-19 during the Omicron era: A multicenter real-world study.J Virus Erad2026https://conductscience.org/library/papers/42282861

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41004466

GET https://conductscience.org/api/papers/v1/41004466/references?page=2